尔康制药(300267.SZ)：暂无“肝纤维化药物”相关研发项目

Group 1 - The company, Erkang Pharmaceutical (300267.SZ), stated that its main business includes the production and sales of excipients, raw materials, finished drugs, and new energy materials [1] - The company currently has no research and development projects related to "liver fibrosis drugs" [1]